Brief: Basilea: Sales Growth For Cresemba And Zevtera Trigger Further Milestone Payments To Basilea

Basilea Pharmaceutica AG, Allschwil

28/01/2025 06:16

Jan 28 (Reuters) - BASILEA PHARMACEUTICA AG ALLSCHWIL
 BSLN.S :
    * STRONG SALES GROWTH FOR CRESEMBA AND ZEVTERA TRIGGER
FURTHER
MILESTONE PAYMENTS TO BASILEA
    * IN TOTAL AMOUNT OF APPROXIMATELY CHF 2.2 MILLION

Source text:  ID:nGNER6hBZ 
Further company coverage:  BSLN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))